Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Thames Water in takeover talks with six suitors

(Sharecast News) - Thames Water said on Tuesday that it has received takeover offers from six potential suitors and that talks with relevant parties are ongoing. While talks are being held, the water company's appeal to the Competition and Markets Authority to raise bills further has been deferred.

Thames Water received the takeover proposals in response to the equity raise process launched in summer 2024. Since then, it has been conducting a detailed assessment of each proposal, it said.

"The company continues to target having agreed transaction terms in the second quarter of 2025, with a view to completing a recapitalisation in the third quarter of 2025," it said.

Thames Water said the proposals involve a range of potential valuations, structures and outcomes for stakeholders.

"Of the five proposals that provided financial metrics, all except one (from a Class B Creditor and with significant conditions attached) indicated a material impairment of the Class A debt. The sixth proposal was for minority equity, intended to partner with investors, and did not set out financial metrics," it said.

"In certain of the contemplated proposals, relevant creditors would receive - in exchange for debt impairment - certain rights to share in future growth in the value of the company, and/or will have the ability to co-invest in the business."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.